This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Columbia University researchers in New York City have reported that worsening depression in older adults is related to higher levels of Alzheimers disease pathology, specifically the accumulation of tau protein. The study was published April 9 in the American Journal of Geriatric Psychiatry. The full study can be found here.
Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 2:00 p.m. | 3:10 p.m. |
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.
Exciting presentations will cover a generative AI model that shows potential for making surgical planning for total hip arthroplasty (THA) more efficient and a deep-learning model developed to identify individuals at high risk of chronic obstructive pulmonary disease (COPD). 1:10 p.m. | 3:20 p.m. | 8:40 a.m. | 9:20 a.m. |
Deuterium metabolic imaging (DMI) was highly aligned with F-18 FDG-PET -- a cornerstone of dementia diagnostics -- in patients with Alzheimer's disease in a study published April 8 in Radiology. However, an exploratory analyses revealed that participants with Alzheimers disease had reduced signals for medial temporal lactate (0.7
For more information on the presentations we're highlighting below and other abstracts, take a look at the RSNA 2023 meeting program. Ga-68 RM2-PET effective in prostate cancer relapse cases Sunday, November 26 | 9:20 a.m.-9:30 9:30 a.m. | Can FDG-PET/MRI radiomics help diagnose rhabdomyosarcoma in children? Thursday, November 30 | 8:10 a.m.-8:20
And 2023 is no exception. Workforce shortages were deemed by our Expert Panel to be the biggest threat in 2023. Congratulations to all the winners of the 2023 Minnies awards, and also to the runners-up and the hundreds of candidates who made the semifinalist list across 15 categories.
Photon-counting CT may serve as an alternative to MRI for assessing liver fat in patients with fatty liver disease, according to an article published September 24 in Radiology. The disease affects up to 24% of the population in the U.S. and can lead to cirrhosis and even cancer if left untreated. in the MASLD cohort.
experience a higher incidence of breast cancer from aggressive molecular subtypes, such as triple-negative disease. The investigators conducted their research in 2023 and 2024. To compare, the triple-negative disease incidence remained unchanged among non-Hispanic white women. per year from 2010 to 2019); and Black women (1.4%
An automated segmentation tool called TotalSegmentator CT was released in August 2023, and since then there has been demand for a similar tool that can be applied across all MRI sequences and anatomic structures, the group explained. To this end, D'Antonoli and colleagues built TotalSegmentator MRI, which they based on nnU-Net.
CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. Interventional In image-guided surgery activities, GEHC showcased two new AI applications previously presented at ECR 2023. MRI GEHC unveiled Signa Champion, a 1.5-tesla,
. | M7-SSPH05-2 | Room N229 Findings will be presented in this Monday afternoon presentation on organ-specific ionizing radiation doses in neonatal patients who undergo interventional procedures for congenital heart disease (CHD). Wong-Siegel has been awarded a 2023 Trainee Research Prize for fellows for the work.
Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”
in 2023 to 16% in 2024 -- a shift likely due to a change in methodology, according to researchers. Centers for Disease Control and Prevention and consists of information from more than 400,000 interviews with adults each year. The BRFSS is a telephone-based health survey conducted by the U.S.
christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
CHICAGO – Black patients receive fewer MRI scans for Alzheimer’s disease diagnosis and undergo imaging at an older age than other racial groups, according to research presented November 27 at RSNA 2023. Additionally, new treatments have recently become available for Alzheimer’s disease that can potentially slow the rate of decline.
The findings could help clinicians tailor biopsy recommendations for men with low- to intermediate risk of the disease, according to the authors. To assess the algorithms potential impact, the team prospectively enrolled 205 men at an average age of 68, from December 2022 to July 2023 at two Seoul hospitals.
People with higher amounts of visceral abdominal fat in midlife may be at increased risk of Alzheimer's disease, according to research to be presented at the upcoming RSNA meeting. A subset of 32 patients underwent PET imaging to identify any amyloid plaque and tau tangles that would indicate the development of Alzheimer's disease.
“The significantly higher lesion-based sensitivity in unsuspected metastases implies a future role of F-18 FAPI PET/CT in evaluation of metastatic disease burden,” the team wrote. The retrospective analysis included data collected in 2022 and 2023 from 38 women with initial clinical stage IIB-IIIC breast cancer. compared to 34.2%
Researchers led by Ashley Pariser, MD, found that while about 93% of individuals recognize a lump as a symptom of breast cancer, less than half recognize other common symptoms tied to the disease. In 2023 alone, medical societies and organizations updated their recommendations for breast cancer screening, though they aren’t uniform.
CHICAGO – Gallium-68 (Ga-68) RM2-PET/MRI is better than MRI alone for detecting relapse in prostate cancer patients, according to research presented November 26 at RSNA 2023. Therefore, Ga-68 RM2-PET should be considered in addition to PSMA-PET in BCR prostate cancer patients to aid in disease detection and management decision, she suggested.
OpenAI's GPT-4 AI model can utilize imaging reports to generate summaries of disease course in patients with complex glioblastoma, improving treatment planning and potentially even enhancing radiology workflows, according to research published July 23 in Radiology. No image data were transmitted to GPT-4.
Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. The Sporadic Early-onset Alzheimer’s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS) Cohort.
milla1cf Tue, 09/26/2023 - 15:32 September 26, 2023 — In a study of more than 2,000 chest X-rays , radiologists outperformed AI in accurately identifying the presence and absence of three common lung diseases, according to a study published in Radiology , a journal of the Radiological Society of North America ( RSNA ).
While care must be individualized, for patients with unknown or unestablished coronary artery disease, the transition to a 'CT first' strategy should be a high priority for cardiovascular care providers," he said. Most study participants were male and white.
Study participants underwent a total of 77 cycles of Y-90-FAPI-46 therapy between June 2020 and December 2023. Lanzafame and colleagues reported that Y-90-FAPI-46 controlled disease progression in nearly half of the patients in the study, signaling a "specific benefit" for the advanced sarcoma patient group. Image courtesy of SNMMI.
Also, women with high levels of unmet social needs were more likely to present with late-stage breast disease. The study included women with stages I-IV invasive ductal or lobular carcinoma treated at an academic medical center from 2020 to 2023.
The authors of a practical guide designed to help radiologists avoid malpractice claims have received one of 17 magna cum laude awards handed out by the RSNA 2023 judges. RSNA 2023 registrants can read the malpractice poster here. Another prizewinner is about imaging of syphilis.
Other partnerships like this] have demonstrated increased patient satisfaction and understanding of their disease process and treatment options through the establishment of multidisciplinary clinics." The final study sample consisted of 579,153 procedures. The complete study can be found here.
Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.
Read more on AuntMinnie.com Related Reading: PCCT effectively images the lumbar spine with lower radiation dose PCCT boosts image quality on CCTA while also reducing contrast need PCCT bests standard CT for evaluating lung structure and function PCCT produces diagnostic CTPA images for PE at low contrast dose PCCT identifies heart disease in high-risk (..)
milla1cf Thu, 06/22/2023 - 20:11 June 22, 2023 — New ultra-high-resolution CT technology enables excellent image quality and accurate diagnosis of coronary artery disease in high-risk patients, a potentially significant benefit for people previously ineligible for noninvasive screening, according to a study published in Radiology.
A model using ultrasonic biomarkers could help physicians identify patients with nonalcoholic fatty liver disease (NAFLD) who have advanced fibrosis, a study presented November 30 at the RSNA 2023 annual meeting found.
Read more on AuntMinnie.com Related Reading: PCCT effectively images the lumbar spine with lower radiation dose PCCT boosts image quality on CCTA while also reducing contrast need PCCT bests standard CT for evaluating lung structure and function PCCT produces diagnostic CTPA images for PE at low contrast dose PCCT identifies heart disease in high-risk (..)
LifeQ offers a 24/7 lens into the body, generating actionable health insights from personal wearable devices and assisting in screening for disease and illness and uncovering its root cause," stated Laurie Olivier, LifeQ CEO and co-founder.
The study included 220 advanced-stage (FIGO III/IV) ovarian cancer patients ages 65 to 67 who were scheduled for primary (n = 27) or interval (n = 193) debulking between 2018 and 2023. that every visible disease has to be removed surgically," Lahaye said. We as radiologists have a problem in depicting disease on CT, peritoneal disease.
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. of patients, noted lead author Ke-Liang Chen, MD, a neurologist at Fudan University. in 2012. “The
The FAI score is one way to capture inflammatory risk beyond the current clinical risk stratification and CCTA interpretation, particularly among patients without obstructive [coronary artery disease], according to Chan, Antoniades, and colleagues. An AI-calculated FAI score can detect and measure vascular inflammation on CCTA exams.
milla1cf Fri, 10/20/2023 - 18:30 October 20, 2023 — Meilleur Technologies, Inc. Amyloid plaques are a hallmark of several neurodegenerative diseases, including Alzheimer’s Disease (AD). The collaboration is focused on using [F-18]NAV-4694 as an imaging biomarker in ADNI4’s neurodegenerative disease research.
They extracted total kidney volume (TKV) from images at three and six months after treatment using an AI tool called TotalSegmentator, a freely available segmentation AI model developed by a Swiss team in 2023. In total, 363 CT studies were included, comprising 121 baseline and 242 follow-up scans. The full study is available here.
There is no cure for the disease, with treatments designed to prolong the lives of patients. Current evidence The best evidence so far on the sequence for these treatments comes from the so-called “RaLu Study,” a medical chart review analysis published in December 2023 in the Journal of Nuclear Medicine.
christine.book Thu, 11/30/2023 - 22:19 December 1, 2023 — The Society of Breast Imaging (SBI) announced that Elizabeth Morris, MD , has been selected as the SBI 2024 Gold Medalist. 27 meeting, held during the Radiological Society of North America Scientific Sessions and Annual Meeting, RSNA 2023.
milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). and accuracy of 93.5%.
christine.book Tue, 10/03/2023 - 11:37 October 3, 2023 — Medical device company GT Medical Technologies, Inc. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA. Kim (2023). Amsbaugh; Catherine S. Brain Metastasis.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content